S961, an insulin receptor antagonist causes hyperinsulinemia, insulin-resistance and depletion of energy stores in rats

Biochemical and Biophysical Research Communications

Volumn 398, Issue 2, 2010, Pages 260-265

  Vikram, Ajit ^a   Jena, Gopabandhu ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Adipose tissue; Antagonist; Insulin; Insulin resistance; Pioglitazone; S961

Indexed keywords

GLUCOSE; GLYCOGEN; HYPERGLYCEMIC AGENT; INSULIN RECEPTOR; PIOGLITAZONE; S 961; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLYCOGEN ANALYSIS; GLYCOGEN LIVER LEVEL; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RESISTANCE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; CELL LINE; GLUCOSE; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; HYPERINSULINISM; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; LIVER GLYCOGEN; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, INSULIN; THIAZOLIDINEDIONES; TRIGLYCERIDES;

RATTUS;

EID: 77955058188     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.06.070     Document Type: Article

References (24)

1. Saltiel A.R., Kahn C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001, 414:799-806.
2. Accili D., Drago J., Lee E.J., Johnson M.D., Cool M.H., Salvatore P., Asico L.D., Jose P.A., Taylor S.I., Westphal H. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat. Genet. 1996, 12:106-109.
3. Islam M.S., Loots du T. Experimental rodent models of type 2 diabetes: a review. Methods Find. Exp. Clin. Pharmacol. 2009, 31:249-261.
4. Vikram A., Jena G.B., Ramarao P. Increased cell proliferation and contractility of prostate in insulin resistant rats: linking hyperinsulinemia with benign prostate hyperplasia. Prostate 2010, 70:79-89.
5. Hong E.G., Ko H.J., Cho Y.R., Kim H.J., Ma Z., Yu T.Y., Friedline R.H., Kurt-Jones E., Finberg R., Fischer M.A., Granger E.L., Norbury C.C., Hauschka S.D., Philbrick W.M., Lee C.G., Elias J.A., Kim J.K. Interleukin-10 prevents diet-induced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle. Diabetes 2009, 58:2525-2535.
6. Biddinger S.B., Kahn C.R. From mice to men: insights into the insulin resistance syndromes. Annu. Rev. Physiol. 2006, 68:123-158.
7. Turner R.C., Cull C.A., Frighi V., Holman R.R. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 1999, 281:2005-2012.
8. Schaffer L., Brand C.L., Hansen B.F., Ribel U., Shaw A.C., Slaaby R., Sturis J. A novel high-affinity peptide antagonist to the insulin receptor. Biochem. Biophys. Res. Commun. 2008, 376:380-383.
9. Shiau C.W., Yang C.C., Kulp S.K., Chen K.F., Chen C.S., Huang J.W., Chen C.S. Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPARgamma. Cancer Res. 2005, 65:1561-1569.
10. Van Der Vies J. Two methods for the determination of glycogen in liver. Biochem. J. 1954, 57:410-416.
11. Lillioja S., Mott D.M., Spraul M., Ferraro R., Foley J.E., Ravussin E., Knowler W.C., Bennett P.H., Bogardus C. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N. Engl. J. Med. 1993, 329:1988-1992.
12. Martin B.C., Warram J.H., Krolewski A.S., Bergman R.N., Soeldner J.S., Kahn C.R. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 1992, 340:925-929.
13. Bruning J.C., Gautam D., Burks D.J., Gillette J., Schubert M., Orban P.C., Klein R., Krone W., Muller-Wieland D., Kahn C.R. Role of brain insulin receptor in control of body weight and reproduction. Science 2000, 289:2122-2125.
14. Obici S., Feng Z., Karkanias G., Baskin D.G., Rossetti L. Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nat Neurosci. 2002, 5:566-572.
15. Obici S., Zhang B.B., Karkanias G., Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat. Med. 2002, 8:1376-1382.
16. Rahmouni K., Morgan D.A., Morgan G.M., Liu X., Sigmund C.D., Mark A.L., Haynes W.G. Hypothalamic PI3K and MAPK differentially mediate regional sympathetic activation to insulin. J. Clin. Invest. 2004, 114:652-658.
17. Koch L., Wunderlich F.T., Seibler J., Konner A.C., Hampel B., Irlenbusch S., Brabant G., Kahn C.R., Schwenk F., Bruning J.C. Central insulin action regulates peripheral glucose and fat metabolism in mice. J. Clin. Invest. 2008, 118:2132-2147.
18. Kimball S.R., Vary T.C., Jefferson L.S. Regulation of protein synthesis by insulin. Annu. Rev. Physiol. 1994, 56:321-348.
19. Schaffer L., Brissette R.E., Spetzler J.C., Pillutla R.C., Ostergaard S., Lennick M., Brandt J., Fletcher P.W., Danielsen G.M., Hsiao K.C., Andersen A.S., Dedova O., Ribel U., Hoeg-Jensen T., Hansen P.H., Blume A.J., Markussen J., Goldstein N.I. Assembly of high-affinity insulin receptor agonists and antagonists from peptide building blocks. Proc. Natl. Acad. Sci. USA 2003, 100:4435-4439.
20. Paranjape S.A., Chan O., Zhu W., Horblitt A.M., McNay E.C., Cresswell J.A., Bogan J.S., McCrimmon R.J., Sherwin R.S. Influence of Insulin in the Ventromedial Hypothalamus on Pancreatic Glucagon Secretion In vivo. Diabetes 2010, 59:1521-1527.
21. Magnusson I., Rothman D.L., Katz L.D., Shulman R.G., Shulman G.I. Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. J. Clin. Invest. 1992, 90:1323-1327.
22. Tomiyasu M., Obata T., Nishi Y., Nakamoto H., Nonaka H., Takayama Y., Autio J., Ikehira H., Kanno I. Monitoring of liver glycogen synthesis in diabetic patients using carbon-13 MR spectroscopy. Eur. J. Radiol. 2010, 73:300-304.
23. Bluher M., Kahn B.B., Kahn C.R. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 2003, 299:572-574.
24. Smith U. Pioglitazone: mechanism of action. Int. J. Clin. Pract. Suppl. 2001, 13-18.